{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.11.1117",
  "meta": {
    "versionId": "22",
    "lastUpdated": "2021-09-14T01:01:12.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1117",
  "version": "20210914",
  "name": "Inactivated Polio Vaccine (IPV) Administered",
  "status": "active",
  "date": "2021-09-14T01:01:12-04:00",
  "publisher": "NCQA PHEMUR",
  "compose": {
    "include": [
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "concept": [
          {
            "code": "90697",
            "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"
          },
          {
            "code": "90698",
            "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
          },
          {
            "code": "90713",
            "display": "Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use"
          },
          {
            "code": "90723",
            "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use"
          }
        ]
      }
    ]
  }
}